Effects of troglitazone on substrate storage and utilization in insulin- resistant rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 6 39-6, 1999, Pages

  Sreenan, Seamus ^a   Keck, Sara ^a   Fuller, Timothy ^a   Cockburn, Brian ^a   Burant, Charles F ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b PFIZER INC   (United States)

Author keywords

Free fatty acid metabolism; Glucose metabolism; Insulin resistance; Non insulin dependent diabetes mellitus; Thiazolidinedione

Indexed keywords

GLYCOGEN; INSULIN; LIPOPROTEIN LIPASE; PALMITIC ACID; PYRUVATE DEHYDROGENASE; TROGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN MUSCLE LEVEL; GLYCOGEN SYNTHESIS; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; SOLEUS MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033032470     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.6.e1119     Document Type: Article

References (39)

1. Aarsland, A., D. Chinkes, and R. R. Wolfe. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J. Clin. Invest. 98: 2008-2017, 1996.
2. Argyraki, M., P. D. Wright, C. W. Venables, G. Proud, and R. Taylor. In vitro study of human skeletal muscle strips: effect of nonesterified fatty acid supply on glucose storage. Metabolism 38: 1183-1187, 1989.
3. Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10, 1997.
4. Burant, C. F., S. K. Lemon, M. K. Treutelaar, and M. G. Buse. Insulin resistance in denervated skeletal muscle: a model for impaired receptor function coupling. Am. J. Physiol. 247 (Endocrinol. Metab. 10): E657-E666, 1984.
5. Burant, C. F., S. Sreenan, K. Hirano, T.-A. Tai, J. Lohmiller, J. Lukens, N. O. Davidson, S. Ross, and R. A. Graves. Troglitazone action is independent of adipose tissue. J. Clin. Invest. 100: 2900-2908, 1997.
6. Chalkley, S. M., M. Gettiarachchi, D. J. Chishom, and E. W. Kraegen. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism 47: 1121-1126, 1998.
7. Cockburn, B. N., and H. G. Coore. Starvation reduces pyruvate dehydrogenase phosphate phosphatase activity in rat kidney. Mol. Cell. Biochem. 149-150: 131-136, 1995.
8. De Vos, P., A. M. Lefebvre, S. G. Miller, M. Guerre-Millo, K. Wong, R. Saladin, L. G. Hamann, B. Staels, M. R. Briggs, and J. Auwerx. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J. Clin. Invest. 98: 1004-1009, 1996.
9. Groop, L. C., R. C. Bonadonna, D. C. Simonson, A. S. Petrides, L. Shank, and R. A. DeFronzo. Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. Am. J. Physiol. 263 (Endocrinol. Metab. 26): E79-E84, 1992.
10. Han, D. H., P. A. Hansen, H. H. Host, and J. O. Hollozy. Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes 46: 1761-1767, 1997.
11. Jensen, J., R. Aslesen, J. L. Ivy, and O. Brors. Role of glycogen concentration and epinephrine on glucose uptake in rat epitrochlearis muscle. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E649-E655, 1997.
12. Koyama, K., G. Chen, Y. Le, and R. H. Unger. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am. J. Physiol. 273 (Endocrinol. Metab. 36): E708-E713, 1997.
13. Lee, Y. H., H. Hirose, M. Ohneda, J. H. Johnson, J. D. McGarry, and R. H. Unger. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc. Natl. Acad. Sci. USA 91: 10878-10882, 1994.
14. Lefebvre, A. M., J. Peinado-Onsurbe, I. Leitersdorf, M. R. Briggs, J. R. Paterniti, J. C. Fruchart, C. Fievet, J. Auwerx, and B. Staels. Regulation of lipoprotein metabolism by thiazolidinediones occurs through a distinct but complementary mechanism relative to fibrates. Arterioscler. Thromb. Vase. Biol. 17: 1756-1764, 1997.
15. Levak-Frank, S., G. Radner, A. Walsh, R. Stollberger, G. Knipping, G. Hoefler, W. Sattler, P. H. Weinstock, L. Breslow, and R. Zechner. Muscle-specific overexpression of lipoprotien lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J. Clin. Invest. 96: 976-986, 1995.
16. Lillioja, S., C. Bogardus, D. M. Mott, A. L. Kennedy, W. C. Knowler, and B. V. Howard. Relationship between insulin-mediated glucose disposal and lipid metabolism in man. J. Clin. Invest. 75: 1106-1115, 1985.
17. Maggs, D. G., T. A. Buchanan, C. F. Burant, G. Cline, B. Gumbiner, W. A. Hsueh, S. Inzucchi, D. Kelly, D. Nolan, J. M. Olefsky, K. S. Polonsky, D. Silver, T. R. Valiquett, and G. I. Shulman. The metabolic effects of troglitazone in non-insulin dependent diabetes: a randomized, double-blind, placebo controlled trial. Ann. Intern. Med. 128: 176-185, 1998.
18. McGarry, J. D., and N. F. Brown. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244: 1-14, 1997.
19. Mondon, C. E., I. R. Jones, S. Azhar, C. B. Hollenbeck, and G. M. Reaven. Lactate production and pyruvate dehydrogenase activity in fat and skeletal muscle from diabetic rats. Diabetes 41: 1547-1554, 1992.
20. Muoio, D. M., G. L. Dohn, F. T. Fiedored, E. B. Tapscott, and R. A. Coleman. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46: 1360-1363, 1997.
21. Nakamura, K., and S. Handa. Coomassie brilliant blue staining of lipids on thin-layer plates. Anal. Biochem. 142: 406-410, 1984.
22. Nilsson-Ehle, P., and M. C. Shotz. A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J. Lipid Res. 17: 536-541, 1976.
23. Oakes, N. D., K. S. Bell, S. M. Furler, S. Camilleri, A. K. Saha, N. B. Ruderman, D. J. Chisholm, and E. W. Kraegen. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA. Diabetes 46: 2022-2028, 1997.
24. Oakes, N. D., G. J. Cooney, S. Camilleri, D. J. Chisolm, and E. W. Kraegen. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46: 1768-1774, 1997.
25. Pan, D. A., S. Lillioja, A. D. Driketos, M. R. Milner, L. A. Baur, C. Bogardus, A. B. Jenkins, and L. H Storlien. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988, 1997.
26. Phillips, D. I., S. Caddy, V. Ilic, B. A. Fielding, D. N. Frayn, A. C. Borhtwick, and R. Taylor. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45: 947-950, 1996.
27. Rayner, D. V., G. D. Dalgliesh, J. S. Duncan, L. J. Hardie, N. Hoggard, and P. Trayhurn. Postnatal development of the ob gene system: elevated leptin levels in suckling fa/fa rats. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R446-R450, 1997.
28. Reaven, G. M. Role of insulin resistance in human disease (Syndrome X): an expanded definition. Annu. Rev. Med. 44: 121-131, 1993.
29. Roden, M., T. B. Price, G. Perseghin, K. F. Petersen, D. L. Rothman, G. W. Cline, and G. I. Shulman. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97: 2859-2865, 1996.
30. Saltiel, A. R., and J. M. Olefsky. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45: 1661-1669, 1996.
31. Shimabukuro, M., Y. T. Zhou, Y. Lee, and R. H. Unger. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J. Biol. Chem. 273: 3547-3550, 1998.
32. Sidossis, L. S., C. A. Stuart, G. I. Shulman, G. D. Lopaschuk, and R. R. Wolfe. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J. Clin. Invest. 98: 2244-2250, 1996.
33. Spiegelman, B. M., and J. S. Flier. Adipogenesis and obesity: rounding out the big picture. Cell 87: 377-389, 1996.
34. Sreenan, S., J. Sturis, W. Pugh, C. F. Burant, and K. S. Polonsky. Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin and troglitazone. Am. J. Physiol. 271 (Endocrinol. Metab. 34): E742-E747, 1996.
35. Storlien, L. H., A. B. Jenkins, D. J. Chisholm, W. S. Pascoe, S. Khouri, and E. W. Kraegen. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40: 280-289, 1991.
36. Sturis, J., W. L. Pugh, J. Tang, and K. S. Polonsky. Prevention of diabetes does not completely prevent insulin secretory defects in the ZDF rat. Am. J. Physiol. 269 (Endocrinol. Metab. 32): E786-E792, 1995.
37. Thorburn, A. W., B. Gumbiner, F. Bulacan, G. Brechtel, and R. R. Henry. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J. Clin. Invest. 87: 489-495, 1991.
38. Unger, R. G. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Diabetes 44: 863-870, 1995.
39. Wititsuwannakul, D., and K. H. Kim. Mechanisms of palmityl coenzyme A inhibition of liver glycogen synthase. J. Biol. Chem. 252: 7812-7817, 1977.